HOWSON TAMAR D 4
4 · MEI Pharma, Inc. · Filed Jul 7, 2020
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
HOWSON TAMAR D
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-07-02+50,000→ 50,000 totalExercise: $3.49Exp: 2030-07-02→ Common Stock (50,000 underlying)
Holdings
- 60,000
Stock Option (Right to Buy)
Exercise: $2.52Exp: 2029-07-01→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The options will vest in equal monthly installments over twelve months.
- [F2]40,000 of the options vested on July 1, 2019 and currently exercisable and 20,000 options will vest in equal monthly installments over thirty-six months beginning July 1, 2019.